STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryReference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Employment Agreement dated August 6, 2010, between the Company and Michael Sinclair, as amended on December 31, 2012, and further amended on December 31, 2013 (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein or in the Letter.
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryAs per the Agreement dated January 22, 2013, as amended, between Lightlake Therapeutics Inc. (the “Company”) and you, you have been granted options (the “Options”) to purchase common stock (the “Common Stock”) of the Company (with each share of Common Stock of the Company, a “Share”) as follows:
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryReference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Director Agreement dated December 31, 2012, between the Company and Geoffrey Wolf (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein or in the Letter.
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryReference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Employment Agreement dated August 6, 2010, between the Company and Michael Sinclair, as amended on December 31, 2012, and further amended on December 31, 2013 (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein or in the Letter.
Warrant GrantWarrant Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryAs per the Agreement dated January 22, 2013, as amended, between Lightlake Therapeutics Inc. (the "Company") and you, you have been granted warrants (the "Warrants") to purchase common stock (the "Common Stock") of the Company (with each share of Common Stock of the Company, a "Share") as follows:
WARRANT GRANTWarrant Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryAs per the Director Agreement dated December 31, 2012, between Lightlake Therapeutics Inc. (the “Company”) and Geoffrey Wolf, the Warrant Holder has been granted warrants (“Warrants”) to purchase Common Stock of the Company (with each share of Common Stock of the Company, a “Share”) as follows:
Stock Option GrantStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryPursuant to the Employment Agreement between Opiant Pharmaceuticals, Inc. (the “Company”) and you effective February 6, 2017 (the “Employment Agreement”), the Company has granted you options (the “Options”) to purchase common stock of the Company (the “Common Stock”) (with each share of Common Stock, a “Share”) as follows:
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryAs per the Letter Agreement dated November 12, 2014 between Lightlake Therapeutics Inc. (the “Company”) and you, you have been granted options (the “Options”) to purchase common stock (the “Common Stock”) of the Company (with each share of Common Stock of the Company, a “Share”) as follows:
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryReference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Senior Advisor Agreement dated January 22, 2013, between the Company and Brad Miles (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein.
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryAs per the Letter Agreement dated November 12, 2014 between Lightlake Therapeutics Inc. (the “Company”) and you, you have been granted options (the “Options”) to purchase common stock (the “Common Stock”) of the Company (with each share of Common Stock of the Company, a “Share”) as follows:
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryReference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Director Agreement dated December 31, 2012, between the Company and Geoffrey Wolf (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein.